Low-molecular-weight heparins (LMWHs) have become the corner stone of antithrombotic treatment but their administration protocol needs to be optimized for certain groups of patients...
Keywords: Tissue factor (TF), thromboelastography, LMWH, nadroparin, carotid artery disease, angioplasty, antithrombotic treatment
01/2007 | Thrombosis and Haemostasis, Schattauer